Revance Therapeutics, Inc. (RVNC) News Headlines

▮ More

Date

Headline

1/22/2019 4:10:02 PM Revance Announces Closing Of Public Offering Of Common Stock

1/17/2019 6:53:06 AM Revance Therapeutics Prices Public Offering Of 5.88 Mln Shares At $17.00 Per Share

12/4/2018 8:09:25 AM Revance Therapeutics Enters License Agreement With Fosun Pharma Industrial

10/11/2018 8:33:24 AM Revance Therapeutics Appoints Tobin Schilke As CFO

5/30/2018 7:10:06 AM Revance Therapeutics (RVNC) Pulled Back After CFO Resigned

5/29/2018 7:02:27 AM Revance Therapeutics CFO Lauren Silvernail Resigns

3/1/2018 9:04:13 AM William Blair Reiterates Revance Therapeutics, Inc. (RVNC) At Outperform

2/28/2018 5:32:32 PM Mylan, Revance Announce License Agreement For Proposed Biosimilar To BOTOX

2/28/2018 4:07:06 PM Mylan To Develop Biosimilar Of BOTOX Through Collaboration And License Agreement With Revance Therapeutics

1/9/2018 6:06:39 AM Hercules Capital Achieves More Than $880 Mln In New Commitments In 2017

1/8/2018 8:37:08 AM Revance Announces Interim Phase 2a Results For RT002 In Treating Plantar Fasciitis

1/2/2018 10:43:49 AM KDMN And 10 Other Biotech Stocks You Should Watch This Month

2/28/2017 7:30:17 AM William Blair Reiterates Revance Therapeutics, Inc. (RVNC) At Outperform

Older Articles